Letter: Hypersecretion of calcitonin in neoplastic conditions.
D000236:Adenoma / Q000503:physiopathology; D007516:Adenoma, Islet Cell / Q000503:physiopathology; D001984:Bronchial Neoplasms / Q000503:physiopathology; D002116:Calcitonin / Q000378:metabolism*; D002276:Carcinoid Tumor / Q000503:physiopathology; D002283:Carcinoma, Bronchogenic / Q000503:physiopathology; D006729:Hormones, Ectopic / Q000378:metabolism*; D006801:Humans; D008545:Melanoma / Q000503:physiopathology; D009377:Multiple Endocrine Neoplasia / Q000503:physiopathology; D009369:Neoplasms / Q000503:physiopathology*; D009384:Paraneoplastic Endocrine Syndromes / Q000503:physiopathology*; D010673:Pheochromocytoma / Q000503:physiopathology; D011863:Radioimmunoassay; D013964:Thyroid Neoplasms / Q000503:physiopathology; D015043:Zollinger-Ellison Syndrome / Q000503:physiopathology
D006729:Hormones, Ectopic; D002116:Calcitonin